Table 2. Detection results of telomerase in urine samples and PARP-1 in cells a .
| Telomerase | Patient ID | Clinical outcome | TRAP | PL intensity |
| 1 | Water | – | 0.25 | |
| 2 | Normal | Normal | – | 0.3 |
| 3 | 1003295831 | Vesical calculus | – | 0.3 |
| 4 | 1008455348 | Bladder cancer | – | 10.5 |
| 5 | 1002693440 | Kidney stone | – | 0.35 |
| 6 | 1008455719 | Kidney stone | – | 0.31 |
| 7 | 1008461668 | Kidney stone | – | 0.29 |
| 8 | 1007144483 | Inflammation | – | 0.25 |
| 9 | 1007677148 | Bladder cancer | + | 5 |
| 10 | 1007922178 | Bladder cancer | + | 4 |
| 11 | 1007045669 | Bladder cancer | + | 12 |
| 12 | 1007924814 | Bladder cancer | + | 7 |
| PARP-1 | Cells | Nucleus (U) | Plasma (U) | |
| 13 | IOSE80 | 0.05 | 0.02 | |
| 14 | MCF-7 | 0.67 | 0.53 | |
| 15 | SK-BR-3 | 0.74 | 0.5 |
a“–” or “+” means negative or positive for telomerase, respectively.